{"nct_id":"NCT05418426","title":"A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women","status":"COMPLETED","status_verified_date":"2023-08","start_date":"2020-08-18","start_date_type":"ACTUAL","primary_completion_date":"2021-04-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["DARE"]}